Sign in

CIK 0001374339

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

ProMIS Neurosciences Inc.

Sign in to watch
Ticker
PMN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Canada (Federal Level)
Entity type
Operating
Phone
+1 416-847-6898
Business address
SUITE 200, 1920 YONGE STREET, TORONTO, Ontario, Canada, M4S 3E2
Former names
AMORFIX LIFE SCIENCES LTD
  1. 4 Grant or award Chief Operating Officer acquired 2,660 shares (grant or award)
  2. 4 Grant or award Chief Scientific Officer acquired 10,643 shares (grant or award)
  3. 4 Grant or award Principal Accounting Officer acquired 13,297 shares (grant or award)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 2,000 shares at an average $4.65 ($9,290)
  6. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $4.94 ($4,940)
  7. 4 Open-market buy Director bought 3,000 shares at an average $4.63 ($13,890)
  8. 4 Open-market buy Director bought 1,000 shares at $5.08 ($5,075)
  9. 4 Open-market buy Director bought 1,000 shares at $4.98 ($4,980)
  10. 4 Open-market buy Director bought 1,000 shares at $5.49 ($5,486)
  11. 4 Open-market buy Chief Executive Officer bought 1,000 shares at $5.70 ($5,700)
  12. 4 Open-market buy Director bought 1,000 shares at $5.98 ($5,980)
  13. 4 Derivatives Options or other derivatives
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market buy Director bought 4,000 shares at $5.92 ($23,680)
  16. 4 Open-market buy Chairman and CEO bought 1,000 shares at $9.80 ($9,800)
  17. 3 Insider Initial Statement of Ownership
  18. 3 Insider Initial Statement of Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 3 Insider Initial Statement of Ownership

Page 5 of 6 · 108 filings